We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to use an interrupted time series to evaluate your digital health product.
Information for patients, healthcare professionals and developers of new medicines
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The penalties if you are caught taking or dealing drugs - drug classification, fines and prison sentences
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Licence and registration application information for companies that deal in precursor chemicals.
You must get permission to export certain drugs and medicines.
Information and resources to support commissioners, service providers and others to reduce harm and prevent deaths related to substance misuse.
Actions that trial sponsors should consider to build resilience into clinical trial design
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Information for companies on the import and export of controlled drugs to and from the UK.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).